These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 10383538)
1. Relative bioavailability of sodium cromoglycate to the lung following inhalation, using urinary excretion. Aswania OA; Corlett SA; Chrystyn H Br J Clin Pharmacol; 1999 Jun; 47(6):613-8. PubMed ID: 10383538 [TBL] [Abstract][Full Text] [Related]
2. Relative lung and systemic bioavailability of sodium cromoglycate inhaled products using urinary drug excretion post inhalation. Aswania O; Chrystyn H Biopharm Drug Dispos; 2002 May; 23(4):159-63. PubMed ID: 12015790 [TBL] [Abstract][Full Text] [Related]
3. Relative lung bioavailability of generic sodium cromoglycate inhalers used with and without a spacer device. Aswania O; Chrystyn H Pulm Pharmacol Ther; 2001; 14(2):129-33. PubMed ID: 11273794 [TBL] [Abstract][Full Text] [Related]
4. Determination of the relative bioavailability of nedocromil sodium to the lung following inhalation using urinary excretion. Aswania OA; Corlett SA; Chrystyn H Eur J Clin Pharmacol; 1998 Aug; 54(6):475-8. PubMed ID: 9776438 [TBL] [Abstract][Full Text] [Related]
5. Relative bioavailability of salbutamol to the lung following inhalation when administration is prolonged. Silkstone VL; Tomlinson HS; Corlett SA; Chrystyn H Br J Clin Pharmacol; 2000 Sep; 50(3):281-4. PubMed ID: 10971315 [TBL] [Abstract][Full Text] [Related]
6. Development and validation of an ion-pair liquid chromatographic method for the quantitation of sodium cromoglycate in urine following inhalation. Aswania OA; Corlett SA; Chrystyn H J Chromatogr B Biomed Sci Appl; 1997 Mar; 690(1-2):373-8. PubMed ID: 9106069 [TBL] [Abstract][Full Text] [Related]
7. Lung deposition after inhalation with various nebulisers in preterm infants. Köhler E; Jilg G; Avenarius S; Jorch G Arch Dis Child Fetal Neonatal Ed; 2008 Jul; 93(4):F275-9. PubMed ID: 18192330 [TBL] [Abstract][Full Text] [Related]
8. Determination of the relative bioavailability of salbutamol to the lungs and systemic circulation following nebulization. Silkstone VL; Corlett SA; Chrystyn H Br J Clin Pharmacol; 2002 Aug; 54(2):115-9. PubMed ID: 12207629 [TBL] [Abstract][Full Text] [Related]
9. Relative lung and total systemic bioavailability following inhalation from a metered dose inhaler compared with a metered dose inhaler attached to a large volume plastic spacer and a jet nebuliser. Silkstone VL; Corlett SA; Chrystyn H Eur J Clin Pharmacol; 2002 Jan; 57(11):781-6. PubMed ID: 11868799 [TBL] [Abstract][Full Text] [Related]
10. Urinary pharmacokinetic methodology to determine the relative lung bioavailability of inhaled beclometasone dipropionate. Said AS; Harding LP; Chrystyn H Br J Clin Pharmacol; 2012 Sep; 74(3):456-64. PubMed ID: 22299644 [TBL] [Abstract][Full Text] [Related]
11. Relative bioavailability of terbutaline to the lung following inhalation, using urinary excretion. Abdelrahim ME; Assi KH; Chrystyn H Br J Clin Pharmacol; 2011 Apr; 71(4):608-10. PubMed ID: 21395654 [TBL] [Abstract][Full Text] [Related]
12. Comparison of three treatment regimens of inhaled sodium cromoglycate in the management of adult patients with severe, steroid-dependent asthma. Sakai H; Shimoda T; Matsuo N; Matsuse H; Obase Y; Asai S; Kohno S; Edwards A Ann Allergy Asthma Immunol; 1998 Jun; 80(6):494-8. PubMed ID: 9647273 [TBL] [Abstract][Full Text] [Related]
13. Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices. Hindle M; Chrystyn H Thorax; 1994 Jun; 49(6):549-53. PubMed ID: 8016791 [TBL] [Abstract][Full Text] [Related]
14. A simple pharmacokinetic method to evaluate the pulmonary dose in clinical practice--analyses of inhaled sodium cromoglycate. Lindström M; Svensson JO; Meurling L; Svartengren K; Anderson M; Svartengren M Respir Med; 2004 Jan; 98(1):9-16. PubMed ID: 14959808 [TBL] [Abstract][Full Text] [Related]
15. Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. Daley-Yates PT; Price AC; Sisson JR; Pereira A; Dallow N Br J Clin Pharmacol; 2001 May; 51(5):400-9. PubMed ID: 11421996 [TBL] [Abstract][Full Text] [Related]
16. Determination of the relative bioavailability of salbutamol to the lung following inhalation. Hindle M; Chrystyn H Br J Clin Pharmacol; 1992 Oct; 34(4):311-5. PubMed ID: 1457264 [TBL] [Abstract][Full Text] [Related]
17. Relative bioavailability of salbutamol to the lung following inhalation via a novel dry powder inhaler and a standard metered dose inhaler. Hindle M; Peers EM; Parry-Billings M; Chrystyn H Br J Clin Pharmacol; 1997 Mar; 43(3):336-8. PubMed ID: 9088593 [TBL] [Abstract][Full Text] [Related]
18. Preventive effect of 2 and 10 mg of sodium cromoglycate on exercise-induced bronchoconstriction. Storm van's Gravesande K; Mattes J; Grossklauss E; Zurmühl A; Moseler M; Kühr J Eur J Pediatr; 2000 Oct; 159(10):759-63. PubMed ID: 11039131 [TBL] [Abstract][Full Text] [Related]
19. [Assessment of the amount of drug deposited in the lungs of asthmatic children using disodium cromoglycate as the marker]. Iwasaki E; Yamaura M; Baba M Arerugi; 1993 Aug; 42(8):907-13. PubMed ID: 8250730 [TBL] [Abstract][Full Text] [Related]
20. Lung deposition after electronically breath-controlled inhalation and manually triggered conventional inhalation in cystic fibrosis patients. Köhler E; Sollich V; Schuster-Wonka R; Jorch G J Aerosol Med; 2005; 18(4):386-95. PubMed ID: 16379615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]